India

Bharat Biotech’s “iNCOVACC” Intranasal Vaccine Price Out Now

Bharat Biotech’s intranasal coronavirus vaccine costs have been announced.

A single dosage of Bharat Biotech’s intranasal vaccine iNCOVACC, which was authorised for inclusion in India’s COVID-19 immunisation programme last week, would cost Rs 800, excluding the 5% Goods and Services Tax (GST) at private hospitals.
The nasal vaccination was authorised by the government last Friday as India prepared to deal with any crisis that arises as a result of the worldwide spike in coronavirus infections. It will be used as a heterologous booster and will be offered first in private institutions.

Where to apply for nasal vaccine?

Starting today, the vaccination will be available through the CoWIN app. In this context, the CoWIN platform will also be changed. Simply check in to your CoWIN account and apply for a vaccination slot. The vaccine will be offered in private hospitals beginning today and will be included in Covid-19 immunisation campaigns.

Who is eligible for nasal vaccine?

Those above the age of 18 can get the iNCOVACC nasal vaccine, which has been licenced by the Government of India and will be used as a heterologous booster dose.
When compared to injectable immunisations, nasal vaccines provide several advantages. Aside from the simplicity of storage, delivery, and waste creation, nasal vaccinations also give protection at the virus’s entrance locations – the nose or upper respiratory tract.

Also Read: COVID Mock Drills TO Take Place All Over India Today

Companies That Took Part in the making

The vaccine was created in collaboration with Washington University in St. Louis, which conceived and produced the recombinant adenoviral vectored construct and tested its effectiveness in preclinical tests.

Bharat Biotech developed products for preclinical safety review, large-scale manufacturing scale up, formulation and delivery device development, and human clinical trials.

The Government of India supported part of the product development and clinical testing through the Department of Biotechnology’s Covid Suraksha programme.

The government has encouraged people who are eligible to take the preventive dose and practise Covid-appropriate behaviour, such as masking and social distance.

On Thursday, Prime Minister Narendra Modi warned people not to be complacent and advised them to wear masks in crowded locations, while also urging officials to increase surveillance procedures, particularly at international airports.

Parth Kakade

Recent Posts

India Scales Down Attari Retreat Ceremony After Pahalgam Terror Attack

India has scaled down the daily Retreat Ceremony at the Attari border. This follows the…

6 mins ago

PM Modi Highlights Panchayats’ Role; Links Bihar’s Legacy To National Growth

PM Modi, in Madhubani on Panchayati Raj Day, emphasised strengthening panchayats and linking Bihar’s culture…

51 mins ago

PM Modi Highlights India’s Growing Steel Sector At India Steel 2025 Conference

PM Modi discusses India’s expanding role and future vision in the global steel industry at…

1 hour ago

Adani Energy Solutions Posts Record Profit In FY25; PAT Doubles To Rs 2,427 Crore

Adani Energy Solutions Ltd (AESL) posted a record FY25 performance, with PAT soaring 103% YoY…

2 hours ago

MCD Mazdoor Sangh Felicitates Amit Kumar Sharma For Promotion And Service

On 21 April 2025, the Delhi Municipal Corporation Engineering Dept Mazdoor Sangh honoured Amit Kumar…

2 hours ago

Calcutta High Court Observes Silence For Pahalgam Victims; Tribute Resonates Across West Bengal Judiciary

The Calcutta HC observed a two-minute silence to honour Pahalgam terror attack victims, following Chief…

2 hours ago